Lilach Steiner

516 total citations
11 papers, 430 citations indexed

About

Lilach Steiner is a scholar working on Molecular Biology, Pharmaceutical Science and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lilach Steiner has authored 11 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmaceutical Science and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lilach Steiner's work include Advancements in Transdermal Drug Delivery (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Receptor Mechanisms and Signaling (2 papers). Lilach Steiner is often cited by papers focused on Advancements in Transdermal Drug Delivery (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Receptor Mechanisms and Signaling (2 papers). Lilach Steiner collaborates with scholars based in Israel, Belgium and United Kingdom. Lilach Steiner's co-authors include Emma McAlister, Aaron J. Courtenay, Lalitkumar K. Vora, Helen O. McCarthy, Galit Levin, Etgar Levy‐Nissenbaum, Ryan F. Donnelly, Alexander Levitzki, Menashe Bar‐Eli and Maelíosa McCrudden and has published in prestigious journals such as Cancer Research, Journal of Controlled Release and European Journal of Pharmacology.

In The Last Decade

Lilach Steiner

11 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lilach Steiner Israel	7	182	170	80	64	49	11	430
Berta Ponsati Spain	13	240 1.3×	32 0.2×	73 0.9×	17 0.3×	36 0.7×	21	497
Serhii Vakal Finland	11	121 0.7×	81 0.5×	24 0.3×	75 1.2×	19 0.4×	26	355
Anlong Liu China	12	139 0.8×	39 0.2×	14 0.2×	36 0.6×	30 0.6×	16	406
Wen‐Yen Huang Taiwan	13	166 0.9×	15 0.1×	140 1.8×	11 0.2×	40 0.8×	30	630
Tanya Singh United States	11	107 0.6×	39 0.2×	27 0.3×	24 0.4×	57 1.2×	23	290
Jason L. Vittitow United States	17	303 1.7×	34 0.2×	29 0.4×	365 5.7×	9 0.2×	40	1.2k
Luisa Riancho France	19	165 0.9×	56 0.3×	55 0.7×	680 10.6×	44 0.9×	30	1.1k
Judit Soós Hungary	8	105 0.6×	143 0.8×	5 0.1×	79 1.2×	31 0.6×	16	334
Margaret George United States	11	175 1.0×	20 0.1×	36 0.5×	9 0.1×	48 1.0×	13	417
Joseph V. Bondi United States	8	104 0.6×	81 0.5×	40 0.5×	4 0.1×	28 0.6×	13	312

Countries citing papers authored by Lilach Steiner

Since Specialization

Citations

This map shows the geographic impact of Lilach Steiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilach Steiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilach Steiner more than expected).

Fields of papers citing papers by Lilach Steiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilach Steiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilach Steiner. The network helps show where Lilach Steiner may publish in the future.

Co-authorship network of co-authors of Lilach Steiner

This figure shows the co-authorship network connecting the top 25 collaborators of Lilach Steiner. A scholar is included among the top collaborators of Lilach Steiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilach Steiner. Lilach Steiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Steiner, Lilach, et al.. (2024). Physiologically-Based Pharmacokinetic Modeling and In Vitro–In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human. Pharmaceutics. 16(7). 896–896. 2 indexed citations

Ventrella, Domenico, Alberto Elmi, Karel Allegaert, et al.. (2021). Animal Models for In Vivo Lactation Studies: Anatomy, Physiology and Milk Compositions in the Most Used Non-Clinical Species: A Contribution from the ConcePTION Project. Animals. 11(3). 714–714. 28 indexed citations

McAlister, Emma, Lalitkumar K. Vora, Zhao Li, et al.. (2021). Microneedle Arrays: Directly Compressed Tablets: A Novel Drug‐Containing Reservoir Combined with Hydrogel‐Forming Microneedle Arrays for Transdermal Drug Delivery (Adv. Healthcare Mater. 3/2021). Advanced Healthcare Materials. 10(3). 4 indexed citations

Courtenay, Aaron J., Emma McAlister, Maelíosa McCrudden, et al.. (2020). Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery. Journal of Controlled Release. 322. 177–186. 125 indexed citations

McAlister, Emma, Lalitkumar K. Vora, Li Zhao, et al.. (2020). Directly Compressed Tablets: A Novel Drug‐Containing Reservoir Combined with Hydrogel‐Forming Microneedle Arrays for Transdermal Drug Delivery. Advanced Healthcare Materials. 10(3). e2001256–e2001256. 69 indexed citations

Francardo, Veronica, Michal Geva, Francesco Bez, et al.. (2019). Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease. Neurotherapeutics. 16(2). 465–479. 53 indexed citations

Johnston, Tom H., Michal Geva, Lilach Steiner, et al.. (2018). Pridopidine, a clinic‐ready compound, reduces 3,4‐dihydroxyphenylalanine‐induced dyskinesia in Parkinsonian macaques. Movement Disorders. 34(5). 708–716. 31 indexed citations

Rabinovich‐Guilatt, Laura, et al.. (2017). Metoprolol‐pridopidine drug–drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease. British Journal of Clinical Pharmacology. 83(10). 2214–2224. 2 indexed citations

Reuveni, Hadas, Efrat Flashner-Abramson, Lilach Steiner, et al.. (2013). Therapeutic Destruction of Insulin Receptor Substrates for Cancer Treatment. Cancer Research. 73(14). 4383–4394. 101 indexed citations

10.

Steiner, Lilach, Galia Blum, Yael Friedmann, & Alexander Levitzki. (2007). ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents. European Journal of Pharmacology. 562(1-2). 1–11. 14 indexed citations

11.

Steiner, Lilach. (1972). [Administration of gentamicin in ophthalmology].. PubMed. 23(4). 131–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact